Table 2 Results of the in vitro patch clamp assay for the developed piperidine analogs in terms of the three monitored Kv1.3 current across time. Chemical structure diversity denotes; ar = aryl ring, r = aliphatic scaffold, x = spacer type and saturation.
Compound Code | Chemical Structure | % remaining activity (mean ± SD; n = 3 at 10 µM) | ||||
---|---|---|---|---|---|---|
Ar | R | X | Peak current amplitude (PCA) | Area under curve–charge (AUC) | Relative time constant (RTC) | |
10a | 4-OMe | -CH = CH- | 92.14 ± 1.87 | 82.49 ± 5.92* | 79.51 ± 2.04 | |
10b | 4-OMe | -CH2-CH2- | 96.45 ± 3.00 | 85.08 ± 6.23 | 82.52 ± 4.02 | |
10c | 4-OMe | -CH2-CH2- | 87.48 ± 1.40** | 62.12 ± 7.16*** | 65.24 ± 9.45*** | |
10d | 4-OMe | -CH2-CH2- | 98.51 ± 1.50 | 74.53 ± 2.16*** | 73.64 ± 7.53* | |
10e | H | -CH2-CH2- | 93.24 ± 4.35 | 69.28 ± 4.50*** | 70.45 ± 3.89** |